Covalon Technologies (OTCMKTS:CVALF) Shares Down 1.3% – What’s Next?

Covalon Technologies Ltd. (OTCMKTS:CVALF)’s share price traded down 1.3% during trading on Thursday . The company traded as low as $1.54 and last traded at $1.54. 800 shares traded hands during trading, a decline of 85% from the average session volume of 5,312 shares. The stock had previously closed at $1.56.

Covalon Technologies Stock Down 1.3%

The company has a market capitalization of $42.53 million, a P/E ratio of 38.51 and a beta of 0.62. The business has a 50 day moving average of $1.45 and a 200 day moving average of $1.34.

Covalon Technologies (OTCMKTS:CVALF) last posted its quarterly earnings data on Thursday, May 21st. The company reported $0.03 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.01 by $0.02. The business had revenue of $6.27 million during the quarter, compared to analyst estimates of $6.70 million. Covalon Technologies had a return on equity of 5.74% and a net margin of 5.05%.

About Covalon Technologies

Covalon Technologies Ltd. (OTCMKTS:CVALF) is a Canadian medical device and life sciences company specializing in advanced wound care and infection prevention solutions. Based in Toronto, Ontario, Covalon leverages proprietary photochemical bonding technology to create antimicrobial and anti-adhesion polymer coatings for a range of medical devices and wound dressings. The company’s core focus is on reducing surgical site infections and improving healing outcomes through innovative biomaterials.

The company’s product portfolio comprises hydrogel-based wound dressings and polymer-coated medical device components.